Immune Tolerance Network Launches Cell Therapy vs. Standard of Care Clinical Trial for Multiple Sclerosis Patients

Immune Tolerance Network Launches Cell Therapy vs. Standard of Care Clinical Trial for Multiple Sclerosis Patients

The Immune Tolerance Network (ITN) has opened the BEAT-MS clinical trial for patient enrollment. BEAT-MS or “Best Available Therapy vs. Autologous Hematopoietic Stem Cell Transplant (AHSCT) for MS” will investigate high dose immunosuppression followed by AHSCT—a type...

Pin It on Pinterest